GlassScriptPhysician profile
Mahmudul Haque
NPI 1639436595
$1,438.38
in general payments reported to CMS, 2019-2025
15 companies · $114 in 2025
The $114 reported for 2025 was less than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
See the full distribution for Nephrology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $420 · 2020: $202 · 2021: $218 · 2022: $148 · 2024: $337 · 2025: $114.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $434 · Education: $17.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $433.87 |
| Education | $17.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $273.51 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $234.49 | 2019-2024 | Lokelma |
| Vifor Pharma, INC. | $142.95 | 2019-2025 | Veltassa |
| Mallinckrodt Hospital Products INC. | $137.48 | 2024-2025 | Terlivaz |
| Glaxosmithkline, LLC. | $125.00 | 2022 | |
| Alexion Pharmaceuticals, INC. | $125.00 | 2019 | |
| Amgen INC. | $110.00 | 2024 | Tavneos |
| Horizon Therapeutics Plc | $53.73 | 2019-2021 | |
| Akebia Therapeutics INC | $48.06 | 2019-2021 | |
| Travere Therapeutics, INC. | $41.36 | 2024-2025 | Filspari |
| Novartis Pharmaceuticals Corporation | $39.98 | 2024 | |
| Fresenius USA Marketing, INC. | $39.77 | 2025 | Velphoro |
| Shire North American Group INC | $23.16 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $22.93 | 2021 | |
| Ardelyx, INC. | $20.96 | 2025 | Ibsrela |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mahmudul Haque listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.